Methylphenidate in attention  deficit hyperactivity disorder  and bipolar disorder.
Kummer
Arthur
A
Teixeira
Antonio
A
D000927:Anticonvulsants / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D015897:Comorbidity; D004359:Drug Therapy, Combination; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008774:Methylphenidate / Q000009:adverse effects / Q000627:therapeutic use*; D014635:Valproic Acid / Q000627:therapeutic use*
D000927:Anticonvulsants; D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D014635:Valproic Acid